EHU060561
MISSION® esiRNA
targeting human NFKBIZ
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
GCCTGGCTAGCAACACTCACTGTCAGTTAGGCAGTCCTGATGTATCTGTACATAGACCATTTGCCTTATATTGGCAAATGTAAGTTGTTTCTATGAAACAAACATATTTAGTTCACTATTATATAGTGGGTTATATTAAAAGAAAAGAAGAAAAATATCTAATTTCTCTTGGCAGATTTGCATATTTCATACCCAGGTATCTGGGATCTAGACATCTGAATTTGATCTCAATGGTAACATTGCCTTCAATTAACAGTAGCTTTTGAGTAGGAAAGGACTTTGATTTGTGGCACAAAACATTATTAATATAGCTATTGACAGTTTCAAAGCAGGTAAATTGTAAATGTTTCTTTAAGAAAAAGCATGTGAAAGGAAAAAGGTAAATACAGCATTGAGGCTTCATTTGGCCTTAGTCCCTG
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... NFKBIZ(64332)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Abhirup Mandal et al.
Science advances, 6(30), eabb6049-eabb6049 (2020-08-25)
Systemic antibodies targeting tumor necrosis factor-α (TNF-α) and interleukin-17A (IL-17A) are effective in plaque psoriasis. Despite their popularity, safety concerns pose a challenge for systemic biologics. While anti-TNF-α and anti-IL-17A antibodies effectively inhibit respective proteins, we hypothesize that an approach
Zhiwen Liu et al.
JCI insight, 5(24) (2020-12-18)
Sepsis is the leading cause of acute kidney injury (AKI). However, the pathogenesis of septic AKI remains largely unclear. Here, we demonstrate a significant decrease of microRNA-376b (miR-376b) in renal tubular cells in mice with septic AKI. Urinary miR-376b in
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EHU060561-50UG | 04061828327058 |
| EHU060561-20UG | 04061828562725 |